NORTH AMERICA CELL THERAPY MARKET FORECAST 2022-2030
The North America cell therapy market is expected to record a CAGR of 14.13% during the forecast period, 2022-2030, and is predicted to reach a
The North America cell therapy market is expected to record a CAGR of 14.13% during the forecast period, 2022-2030, and is predicted to reach a
The France cell therapy market is set to record a CAGR of 15.92% during the forecast period, 2022-2028, and is projected to garner a revenue
In terms of revenue, the global epilepsy devices market was valued at $611.26 million in 2021, and is expected to reach $1203.70 million by 2030,
The Asia-Pacific epilepsy devices market is expected to grow with an 8.05% CAGR by 2030, and is anticipated to generate $314.04 million during the estimated
The Europe epilepsy devices market is predicted to propel with a 7.61% CAGR by 2030, anticipated to generate $325.53 million in revenue during the assessment